Privia Health Group Inc (PRVA)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $3.14B
Last updated: Nov 17, 2026 at 4:20 PM ET
Privia Health Group Inc (PRVA) Statistics
Privia Health Group (PRVA) has a market cap of $3.14B and an enterprise value of $2.69B. Its share count is up 3.88% from a year earlier. Its trailing P/E of 58.1x is above its 5-year median of 37.7x.
Total Valuation
Enterprise value is 14.23% below the market cap, as cash exceeds debt.
| Market Cap | $3.14B |
|---|---|
| Enterprise Value | $2.69B |
| Latest price (Nov 17, 2026) | $24.99 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.3x and 3.9x. Its year-end P/E ranged from 25.1x to 44.3x from 2022 to 2025.
| P/E Ratio | 58.1x |
|---|---|
| Forward P/E | 86.0x |
| P/S Ratio | 1.3x |
| Forward P/S | 1.2x |
| P/B Ratio | 3.9x |
| P/TBV Ratio | 8.3x |
| P/OCF Ratio | 29.0x |
| PEG Ratio | 0.9 |
Enterprise Valuation
Counting debt and cash, the company is valued at 38.5x EBITDA.
| EV / Earnings | 69.7x |
|---|---|
| EV / Sales | 1.1x |
| EV / EBITDA | 38.5x |
Price Statistics
The stock is up 6.57% over 52 weeks and trades 15.80% above its 50-day average.
| Beta (1Y) | 0.29 |
|---|---|
| 52-Week Change | +6.57% |
| 1-Month Change | +11.36% |
| 3-Month Change | +16.29% |
| 6-Month Change | +7.30% |
| 5-Year Change | -16.42% |
| Total Return (1Y) | +6.57% |
| Total Return (3Y CAGR) | +2.95% |
| Total Return (5Y CAGR) | -3.76% |
| Return vs SPY (1Y) | -3.52% |
| Max Drawdown (1Y) | -32.03% |
| Max Drawdown (3Y) | -33.57% |
| Sharpe Ratio (1Y) | 0.24 |
| Correlation with SPY (1Y) | 0.12 |
| 50-Day Average | $21.58 |
| 200-Day Average | $22.69 |
| 52-Week Range | $18.91 to $28.82 |
| RSI (14 Days) | 68.1 |
| Average Volume (20 Days) | 1.37M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.63x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.63x |
|---|---|
| Quick Ratio | 1.63x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 4.73% over the last 12 months, against a 5-year average of -7.32%.
| Return on Equity (ROE) | 4.73% |
|---|---|
| Return on Assets (ROA) | 2.47% |
| ROE (5Y Average) | -7.32% |
| ROA (5Y Average) | -4.70% |
| ROIC (5Y Average) | -18.63% |
| Asset Turnover | 1.67x |
| Receivables Turnover | 4.07x |
Taxes
Income tax took 37.40% of pretax income over the last 12 months.
| Income Tax (TTM) | $23.07M |
|---|---|
| Effective Tax Rate | 37.40% |
Scores
PRVA has an Altman Z-Score of 4.66, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.66 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $2.43B over the last 12 months is up 19.19% from the 12 months before.
| Revenue | $2.43B |
|---|---|
| Revenue Growth (YoY) | +19.19% |
| Gross Profit | $2.16B |
| Operating Income | $51.01M |
| Pretax Income | $61.70M |
| Net Income | $38.62M |
| EBITDA | $71.10M |
| Reported EPS (TTM) | $0.43 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 52.29% of the $1.56B in total assets.
| Cash and Equivalents | $446.28M |
|---|---|
| Total Debt | $0 |
| Net Cash | $446.28M |
| Net Cash Per Share | $3.50 |
| Working Capital | $425.20M |
| Shareholder Equity | $815.72M |
| Book Value Per Share | $6.40 |
| Tangible Book Value | $384.63M |
| Tangible Book Per Share | $3.02 |
| Total Assets | $1.56B |
| Total Liabilities | $690.80M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | $108.07M |
|---|---|
| FCF Per Share | $0.84 |
| Depreciation and Amortization | $12.80M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 2.10%, against a 5-year average of -4.02%.
| Gross Margin | 88.73% |
|---|---|
| Operating Margin | 2.10% |
| Pretax Margin | 2.53% |
| Net Margin | 1.59% |
| EBITDA Margin | 2.92% |
| Gross Margin (5Y Average) | 86.48% |
| Operating Margin (5Y Average) | -4.02% |
| Net Margin (5Y Average) | -3.39% |
Growth
Revenue grew 16.10% a year over 3 years, and EPS 4.89% a year.
| Revenue Growth (3Y CAGR) | +16.10% |
|---|---|
| Revenue Growth (5Y CAGR) | +21.04% |
| EPS Growth (3Y CAGR) | +4.89% |
| EPS Growth (5Y CAGR) | +43.10% |
| FCF Growth (3Y CAGR) | +51.02% |
| FCF Growth (5Y CAGR) | +33.32% |
| Book Value Per Share Growth (2Y CAGR) | +12.13% |
| Tangible Book Per Share Growth (2Y CAGR) | -2.71% |
Dividends and Yields
PRVA does not pay a dividend.
| Earnings Yield | 1.72% |
|---|---|
| Buyback Yield | -0.01% |
Peer Position
Against 9 similar companies, PRVA has the highest P/E.
P/E RatioPeer median 29.6x
P/S RatioPeer median 3.4x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.91%
| P/E Ratio | 58.1x vs 29.6x median |
|---|---|
| P/S Ratio | 1.3x vs 3.4x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +19.19% vs +6.91% median |
Analyst Forecast
Consensus estimates put revenue growth at 14.46% and EPS growth at 30.96% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +14.46% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +30.96% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PRVA
What is PRVA's market cap?
Privia Health Group has a market cap of $3.14B. Its enterprise value, which adds debt and subtracts cash, is $2.69B.
What is PRVA's P/E ratio?
Privia Health Group has a trailing P/E ratio of 58.1x and a forward P/E of 86.0x.
How many shares of PRVA are outstanding?
Privia Health Group has 127.54M shares outstanding. The count is up 3.88% from a year earlier.
Does PRVA pay a dividend?
No. Privia Health Group does not pay a dividend.
How much debt does PRVA have?
Privia Health Group has $0 of total debt and $446.28M of cash and equivalents, a net cash position of $446.28M.
PRVA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors